Genzyme Reminds Sanofi Offer is Too Low

Market News Video
November 09, 2010 AT 11:53 AM
Late yesterday, Sanofi-Aventis (SNY) requested that Genzyme (GENZ) allow its shareholders to decide for themselves whether Sanofis unsolicited offer to the company is a good deal, and Genzyme responded, once again, by saying No, thanks. In a statement and published letter to Sanofis CEO, Genzyme reiterated that the $69 per share undervalues the company.